COVID-19: Vaccines and Therapeutics

The Centers for Disease Control and Prevention revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna鈥檚 vaccine deemed most effective at preventing hospitalizations.
The Department of Health and Human Services鈥 Assistant Secretary for Preparedness and Response announced a major change in the distribution of COVID-19 monoclonal antibody therapies.
The Department of Health and Human Services鈥 (HHS) Assistant Secretary for Preparedness and Response (ASPR) Sept. 13 announced a major change in the distribution of COVID-19 monoclonal antibody therapies.
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19 vaccine confidence in the hospital field, clinicians and the public.
A pair of peer-reviewed studies published in the New England Journal of Medicine are affirming the safety and effectiveness of Pfizer鈥檚 COVID-19 vaccine, first at six months following a completed, two-dose regimen, and then with boosters.
The 黑料正能量 Association (AHA) announced that the organization received $1 million in grant funding from the Centers for Disease Control and Prevention (CDC) to continue COVID-19 vaccine confidence efforts through September 2022.
State and territorial health departments have resumed distributing monoclonal antibodies to clinical sites, the Department of Health and Human Services announced.
AHA hospitals and partners have found several effective strategies that have been successful in increasing vaccine uptake. Over the coming weeks, we will highlight different strategies and examples of how they have been used to improve vaccine confidence.
More school-age children have returned to in-person learning during the last few weeks. More employees are returning to their workplaces. Sports stadiums are filling with spectators again, and theaters and concert venues are welcoming back audiences.